1. Home
  2. PVL vs OVID Comparison

PVL vs OVID Comparison

Compare PVL & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVL
  • OVID
  • Stock Information
  • Founded
  • PVL 2011
  • OVID 2014
  • Country
  • PVL United States
  • OVID United States
  • Employees
  • PVL N/A
  • OVID N/A
  • Industry
  • PVL Oil & Gas Production
  • OVID Biotechnology: Pharmaceutical Preparations
  • Sector
  • PVL Energy
  • OVID Health Care
  • Exchange
  • PVL Nasdaq
  • OVID Nasdaq
  • Market Cap
  • PVL N/A
  • OVID 47.1M
  • IPO Year
  • PVL N/A
  • OVID 2017
  • Fundamental
  • Price
  • PVL $1.48
  • OVID $0.30
  • Analyst Decision
  • PVL
  • OVID Strong Buy
  • Analyst Count
  • PVL 0
  • OVID 6
  • Target Price
  • PVL N/A
  • OVID $3.03
  • AVG Volume (30 Days)
  • PVL 58.5K
  • OVID 409.4K
  • Earning Date
  • PVL 01-01-0001
  • OVID 03-11-2025
  • Dividend Yield
  • PVL 6.29%
  • OVID N/A
  • EPS Growth
  • PVL N/A
  • OVID N/A
  • EPS
  • PVL 0.09
  • OVID N/A
  • Revenue
  • PVL $4,339,313.00
  • OVID $566,000.00
  • Revenue This Year
  • PVL N/A
  • OVID N/A
  • Revenue Next Year
  • PVL N/A
  • OVID $36.11
  • P/E Ratio
  • PVL $18.25
  • OVID N/A
  • Revenue Growth
  • PVL N/A
  • OVID 44.39
  • 52 Week Low
  • PVL $1.03
  • OVID $0.30
  • 52 Week High
  • PVL $1.96
  • OVID $3.45
  • Technical
  • Relative Strength Index (RSI)
  • PVL 42.28
  • OVID 26.39
  • Support Level
  • PVL $1.52
  • OVID $0.30
  • Resistance Level
  • PVL $1.57
  • OVID $0.35
  • Average True Range (ATR)
  • PVL 0.04
  • OVID 0.04
  • MACD
  • PVL -0.01
  • OVID -0.01
  • Stochastic Oscillator
  • PVL 10.00
  • OVID 0.75

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.

Share on Social Networks: